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Editorial
From science council to
health and medical
research organisation
25 years of MRC history
The Silver Jubilee of the Medical Research Council on 1 July
1994 provides a rather special vantage point in time from
which to view the past, present and future of this key
organisation in the health structure of our country. The early
history and development of the MRC, from its modest
beginnings as a committee under the auspices of the CSIR
in 1946 to a fully fledged autonomous science council in
1969, has been fully documented'·' and does not require
repetition at this stage. A holistic look at the general trends
in its development - especially over the last few years -
seems however to be appropriate. The previous review after
21 years by founder President A. J. Brink entitled 'Medical
research: from pastime to profession" describes the main
events up to that point from the first, relatively
unco-ordinated, pioneering efforts of a small
number of amateur enthusiasts to the
development of formal structures for
organisation, funding and professionalisation of
medical research in this country. In this role the
MRC was markedly successful, enabling Brink to
state: 'The most important event for promoting
medical research in South Africa was the
establishment of the South African Medical
Research Council in 1969'. The external
environment of the first 20 years was largely
stable and well-disposed, the economy of the country was
booming and the opinions of the voting public and political
decision-makers followed international trends to create and
maintain idealistic structures such as science councils and
state corporations for developing our country's capacity for
international participation and competition in the scientific
milieu of the developed world. The amount of benefit
conferred by these activities on the average voteless citizen
of the country was of less concern, as were cost-benefit
ratios and the amount of practical implementation of
research results in the health care services.
The years since then have been characterised by acute
and turbulent changes on a vast scale in the external
environment of the MRC. These political, economic and
demographic changes altered the situation of South Africa in
the world, and that of the MRC in South Africa.
The positioning of the MRC in the mainstream of our
health care system as chief problem solver, custodian of a
research mentality and generator of capacity is critically
important to ensure its proper acceptance and credibility
among its clients and stakeholders. At the same time,
practical expediency and short-term views should not be
allowed to cloud the basic truth that reliable research can
only be built on a strong foundation of academic excellence
and true scientific expertise. Our predecessors built the
MRC on these foundations and they built well. The change
in perspective between the 'old' and the >new' MRC is,
however, best illustrated by the change 5 years ago of its
motto from 'Scire volumus (we wish to know)' to the modern
'Shaping a healthy future'.
These new views are most conveniently embodied in the
concept of 'essential national health research' (ENHR);
which emphasises the holistic approach to health problem
solving by research linked as closely as possible to health
service intervention and implementation. It has not been
long since the adoption of this model by the MRC, but
already many stifling interdisciplinary and occupational
barriers are coming down to yield fluid multidisciplinary
networks that militate against the previous
compartmentalisation of our research efforts.
The integrated research portfolio is presently carried out in
7 national programmes, 4 special programmes, 2 centres
and 13 units at universities and by more than 300 individual
grant holders, encompassing about 1 000 highly qualified
researchers with a formidable support infrastructure. This
capacity, both in human and physical terms, is a precious
national asset which needs fostering with care and
appreciation, to continue yielding its full potential value.
It is fitting and timely. indeed that at this stage in the
history of our country, when we are making a new beginning
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in so many areas, the term of office of the present MRC
Board has been completed and a new Board is to be
appointed for the next 3 years. The new Board will be
looked upon with great expectations, not only by the MRC
as a whole, but by the broader academic and research
communities as well as the other important stakeholders in
the health sector. Its leadership and vision at this crucial
stage will play a decisive role not only in the future of the
MRC, but in the viability, quality and place of research in the
health structure as a whole. We place our trust in their ability
fully to realise the value of what has been achieved but,
even more, what can be achieved by the management and
utilisation of this valuable national asset to its full potential.
The mettle of the MRC, its role, objectives and abilities,
were and are still being severely tested, but it has withstood
the challenges of time and circumstances remarkably well,
underpinned by the excellence of its people and by pro-
active strategic planning leading to appropriate redirection
and rationalisation. Times of radical change like these have
always offered great opportunities, to be seized strongly and
positively, to the benefit of long-term development and
future prospects of the organisation. We are now in such a
period with the window of opportunity beckoning us into the
next quarter of a century of achievement and service in the
interest of the health of our people.
O. W. Prozesky
President, MRC
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The colon as a
metabolic ,organ
Walker' has for many years championed the role of diet as a
cause and a prevention of disease. Working alongside
Burkitt, he highlighted the strong negative association
between dietary fibre intake and 'westernised' diseases of
the colon. Perhaps the strongest association noted was'
between dietary fibre intake, stool weight and colon cancer
risk' However, as is often the case in medicine, the picture
is not that simple. A diet high in fibre usually means a 'poor'
diet, which is also low in animal products. Consequently it is
not surprising that further studies have shown positive
associations with animal protein and fat.' The other side of
the coin, however, is that such diets are inevitably rich in
carbohydrates.
Much excitement has arisen from the observation that
fibre is not the only carbohydrate that escapes digestion in
the small intestine - 2 - 20% of so-called 'digestible starch'
may also be malabsorbed and enter the colon.' However,
examination of stool carbohydrate content shows a virtual
absence of carbohydrate, and studies involving intubation
of the whole small intestine with perfusion of the colon with
50 g and 100 g of carbohydrate have demonstrated
complete metabolism within the colon.s It therefore appears
that neither fibre nor undigested carbohydrate contribute to
the bulk of stools, but provide colonic bacteria with
substrate for their metabolic needs. This is consistent with
estimates of the energy requirements of colonic bacteria
which suggest that at least 70 g is required per day· - a
figure clearly in excess of the usual dietary fibre intake of
15 - 30 g/day.
So what is the purpose of colonic bacteria? Are they
there simply to 'mop up' maldigested carbohydrate?
Comparative physiological studies in cows and horses
provide part of the answer to this question. Ruminants (e.g.
the cow) have a specialised section of the stomach that
does not secrete acid. It therefore becomes heavily
colonised with bacteria. Undigested food is first fermented
by these bacteria to produce various gases, such as
hydrogen and methane, and short-chain fatty acids, such as
acetic acid, butyric acid and propionic acid. In turn, these
substances are absorbed and proVide most of the energy
required by the animal. The gases are also absorbed and
then excreted in breath. The horse does the same, but the
fermentation process occurs lower down the gastro-
intestinal tract in the caecum - as in man. However,
quantitatively humans are different, since they consume
relatively lower quantities of carbohydrate, most of which is
absorbed through the usual process of pancreatic digestion
and absorption in the small intestine. Estimates suggest that
colonic short-chain fatty acid production in man contributes
only 5 - 15% of the body's energy needs.'
Possibly more important is the recognition that short-
chain fatty acids are the chief respiratory fuels for colonic
cells. Roediger,· in colonic tissue perfusion studies, showed
that in contrast to previous belief butyrate, and not glucose,
was the preferred metabolic fuel for colonic cells. Further
studies by Windmueller9 demonstrated that the amino acid
glutamine was the chief fuel for the small-intestinal cells,
with glucose taking third place after butyrate.
The importance of this observation was recognised when
Harig et·a/. 1O demonstrated that diversion colitis, a condition
that develops when the colon is separated from the
intestinal stream, is a short-chain fatty acid deficiency state.
.Perfusion of the disconnected segment of colon with sh.ort-
chain fatty acids reversed the condition both clinically and
histologically. Noting the close similarity between diversion
colitis and ulcerative colitis, Roediger" investigated the
metabolism of short-chain fatty acids and noted that, while
he was unable to detect short-chain fatty acid deficiency,
there appeared to be a partial block of its metabolism:
Hypothesising that the metabolic block could be bypassed if
substrate concentrations were increased, Sheppach qnd
colleagues" performed a controlled study in which patients
with distal colitis were given rectal infusions of either
placebo or butyrate for a2-week cross-over trial. The study
supported the hypothesis, with significant improvement in
clinical symptoms and histological changes after butyrate
but not after placebo. Furthermore, they measured the effect
of treatment on colonic crypt cell differentiation using a
method based on the in vitro incorporation of tritiated
thymidine. The results demonstrated that the colitis patients
had an abnormal proliferation index, associated with
increased risk for malignant change. After treatment cellular
proliferation returned to normal, raising the intriguing
possibility that this form of nutritional therapy might reduce
the long-term risk of neoplastic change - bearing in mind
that patients with ulcerative colitis have an increased risk of
developing colon cancer. The antineoplastic potential of
butyrate has been confirmed by cell culture studies."
A further important message from the study is the
implication that 'bowel rest' may not only be unhelpful in the
management of acute attacks of ulcerative colitis, but may
even retard resolution. This is consistent with evidence that
no controlled clinical trial has yet been able to show benefit
from this unfortunately still much-used technique. 14,15
So what does this mean for South African medicine? The
hypothesis could explain the remarkably low incidence of
colonic disorders such as ulcerative colitis, polyposis and
colon cancer in black South Africans. Nutritional studies
have confirmed that their usual diet has a high carbohydrate
content,'· which, by extrapolation, could lead to increased
delivery of carbohydrate to the colon, increased bacterial
metabolism, increased short-chain fatty acid production and
consequently improved cellular nutrition and health. In
further support of this contention, Segal and colleagues17 .
have shown that maize meal, the chief dietary carbohydrate
source in this population group, is incompletely absorbed
and that faecal butyrate production is elevated.'· Recent
fascinating studies have indicated that the composition of
the bacterial flora may also be an important determinant of
disease. There is evidence that increased hydrogen
production may be toxic to the colon." Certain bacteria,
such as methanogenic bacteria, are more effective in the
Volume 84 No. 7 July 1994 SAMJ
disposal of hydrogen, whereas others, such as sulphate-
reducing bacteria, use hydrogen to produce toxic
byproducts.20 We know that methanogenic bacteria are more
common in black than in white South Africans!' Are
sulphate-reducing bacteria less common?
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Bone mass measurement
and the diagnosis of
osteoporosis
Osteoporosis is a disease characterised by increased bone
fragility and a consequent increase in the likelihood of
fracture, which usually involves the spine, hip or wrist.
The disease is common (affecting one out of every three
westernised postmenopausal females), costly (acute fracture
care in the USA alone exceeded $10 billion in 1990) and
causes considerable morbidity and mortality (12 - 20% of
hip fracture victims die within 1 year and less than 50% ever
regain the functional capability to lead an independent Iife)Y
EDITORIAL
Skeletal fragility in osteoporosis results from a reduced
bone mass (osteopenia) and/or qualitative, micro-
architectural deterioration of bone tissue. Bone mass (bone
mineral density; BMD) is however the principal determinant
of bone strength, accounting for 75 - 85% of the variance in
bone strength measured in vitro.' During the past three
decades numerous methods have been developed to
quantitate BMD. Qualitative, structural properties of bone
are said to account for the remaining 15 - 25%, but cannot
be readily assessed by currently available techniques and
may assume greater importance under certain
circumstances.
If most of the variance in bone strength is attributable to
bone density, do fractures result from a low BMD? Recent
studies have firmly established a gradient of increasing
fracture risk corresponding to declining levels in BMD.'·s In
fact, the exponential increase in fracture incidence with
diminishing bone mass is more impressive than the
relationship between serum cholesterol and the risk of
coronary heart disease.3Numerous studies have reported
that a decrease in BMD of 2 standard deviations (see T-
score later) is associated with a 4 - 8-fold increase in spine
and 2 - 4-fold increase in non-spine fracture probability.3"
Bone mass measurement is however not a diagnostic test
for fracture. Rather, it measures a risk factor (Le. reduced
BMD) for future fractures, analogous to measurement of
other risk factors like cholesterol for coronary heart disease
or blood pressure for stroke.
Given the fact that bone mass predicts the probability of
fracture, can bone mass be measured accurately and
safely? The detection of a low BMD by conventional radio-
graphy is notoriously unreliable since 30 - 50% of skeletal
mass must be lost before osteopenia can be detected on
routine radiographs.3.' Moreover, 20 - 30% of patients with
radiographic osteopenia or vertebral fractures have a normal
BMD and may not be at increased risk of subsequent
fracture - the appearance of osteopenia often results from
technical faults, while apparent osteoporotic fractures may
represent juvenile epiphysitis, an old traumatic fracture or
even normal variations in vertebral body shape.3Although
the diagnosis of osteoporosis should not be based on
conventional radiography, spinal radiography continues to
be a substantial aid in diagnosing and in following the
course of the disease. The semiquantitative evaluation of
vertebral deformities proposed by Genant et al. ': reduction
of vertebral height by 20 - 25% - mild; 25 - 40% -
moderate; and> 40% - severe, is particularly useful in this
regard.
Dual photon absorptiometry (OPA), quantitative computed
tomography (QCl) and, since 1987, dual energy X-ray
absorptiometry (OEXA) are established techniques capable
of quantitating bone mass accurately and precisely.
Recently lateral DEXA and morphometric X-ray absorptio-
metry (MEXA) have been introduced.' QCT allows separate
measurement of integrated and trabecular bone (which has
a turnover rate approximately 8 times as high as that of
cortical bone) and therefore detects bone loss earlier.
Precision (3 - 6%) and radiation dose (50 - 100 IJSv) are
higher, which makes this method less ideal for patient
follow-up. OEXA has a high precision (1 %) and a low
radiation dose (1 IJSv) and is also capable of measuring
femoral BMO? Ultrasound densitometry of the calcaneus
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measures both bone density and structure (elasticity).
Excellent precision (1 - 2%) and a strong correlation with
spine BMO (r = 0,83 - 0,95) have been reported. IQ
There is now compelling evidence that a number of
pharmacological agents prevent bone loss and reduce
fracture rate by 50% or more. '-
3 One of the major problems
in the management of patients with osteoporosis involves
the early detection of asymptomatic cases. Assessment of
historical risk factors for the development of osteoporosis is
an essential part of any patient work-up. Known risk factors
do not, however, account for more than 50% of the
variability in bone mass and lack the necessary sensitivity
and precision to screen potential patients adequately."
Biochemical parameters of bone turnover have also been
advocated, but direct bone mass measurement is currently
the only reliable method to assess fracture risk.
Many potential indications for bone mass measurement
have been proposed. These range from unselected
screening, to what I regard as the now outdated indications
recommended by the Scientific Advisory Board of the
American National Osteoporosis Foundation, published in
1989." Clearly, universal (mass)'screening is unlikely to be
cost-effective in this country. More realistic indications could
include: (f) patients with disorders known to affect bone
adversely, e.g. Cushing's syndrome, hyperparathyroidism,
chronic steroid, thyroid and anticonvulsant therapy, hypo-
gonadism and chronic immobilisation; (if) assessment of
perimenopausal women for possible initiation of oestrogen
replacement therapy; (iif) confirmation of osteopenia
suspected from standard radiographs or historic risk factors;
and (iv) initial assessment of severity and site(s) of bone
loss. If BMO suggests low fracture risk, conservative life-
style adaptations and follow-up may be all that is required.
More severe bone loss argues for pharmacological
intervention with anti-resorbing agents (e.g. oestrogen,
bisphosphonates, calcitonin), while marked osteopenia may
suggest use of bone formation stimulating drugs (e.g.
enteric-coated fluoride, anabolic steroids). Bone loss is not
always generalised - while certain agents are known to
improve vertebral bone mass, other drugs need to be
considered if the cortical bone of the hip is predominantly
affected. I.>
Monitoring (e.g. every 12-18 months) of bone mass during
treatment for osteoporosis is necessary since individual
sensitivity to drugs employed in the management of
osteoporosis is well established, with 10 - 30% of patients
not responding to conventional doses of, for example
oestrogen or fluoride.
Skeletal fracture is primarily determined by absolute bone
density, regardless of age. The use of the so called T-score
(expressing the patient's BMO as the deviation from the
mean of the peak BMO of young normal adults) has
therefore become the customary method to interpret BMO
values. A reduction in the T-score of 2 standard deviations
(SO) is a commonly used diagnostic criterion for significant
osteopenia.3-7 While osteopenia is most commonly the result
of osteoporosis, it may also occur secondary to primary
hyperparathyroidism, osteomalacia or combinations of these
so-called metabolic bone diseases. Use of the generic term
osteopenia avoids false assumptions regarding aetiology
and implies that the aetiological investigation has only just
begun. A limited biochemical evaluation and conventional
skeletal radiology should therefore always accompany
densitometry, which could then be interpreted as follows:
(f) T-score within 1SO of the norm = normal; (it) T-score
1- 2,5 SO below the norm = low BMO; (iif) T-score decreased
by > 2,5 SO, without abnormal biochemistry or radiological
evidence of fracture = osteoporosis; (iv) similar to (iif), but
fractures present = severe osteoporosis. More detailed
tests, including quantitative bone histology, may be required
in problem cases.
Significant differences in the BMO of apparently
comparable population groups have been reported, findings·
which argue strongly forthe establishment of our own
normative data for local populations. We have found that
healthy white subjects have BMO values comparable to
those of American controls. In this issue of the SAMJ, Kalla
and co-workers (p. 398) report significant differences and
also challenge current dogma that lumbar BMO decreases
earlier than femoral BMO. The authors are to be
commended and it is hoped that further studies, especially
those involving different ethnic groups and males, will Jollow.
The views expressed above are largely my Qwn. Surely the
time has now come for wider deliberation, collation of
opinions and data, and clear directives on the indications for
densitometry, the appropriate techniques and necessary
quality controls to measure bone mass accurately and
reproducibly, correct interpretation of data and realistic price
structures for such measurements. The newly established
National Osteoporosis Foundation provides, to my mind, the
appropriate forum to realise these aspirations and
colleagues are urged to contact the Foundation at PO Box
481, Bellville, 7535.
Stephen Hough
Department of Endocrinology and Metabolism,
University of Stellenbosch
Tygerberg, W. Cape
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OPINION
Medical schemes'
responses to the amended
Medical Schemes Act and
the ANC Health Policy
Document
It is a fact that the medical schemes industry is under
pressure. This was described in a recent article by Fourie
_and Marx' in which they analysed membership
demographics, financial health and sustainability of
schemes according to 1990 figures.' The picture for the
period 1991 - 1993 is no brighter, and notice must be taken
of the Fourie and Marx conclusion that survival of schemes
is dependent on cost containment, advance provision for
pensioner benefits and actuarial valuation.' In considering
some of the causes of the crisis, quite apart from the effects
of those cost-drivers which exist in a section of the South
African population which is clamouring for the best possible
care in facilities equipped with the latest technology, medical·
schemes are also faced with the problem of a growing
ageing population: in terms of membership of schemes, the
ratio of active to continuing and widowed members has
declined from 15,3:1 to 7,0:1 over the past 6 years.'
Price and Masobe, in their paper on the future of medical
schemes! pick up on the financial burden of the ageing
population, but discuss it in the context of the amendments
to the Medical Schemes Act? Their view is that far from
improving the situation, the deregulation of the medical
schemes industry will cause another extremely serious
problem as employers and medical schemes are forced to
abandon higher-risk members or squeeze them out of the
system, depositing them on the doorstep of the State.
Added to the above threats to the medical schemes
industry are the economic downturn and the entrance into
medical schemes of lower-income earners and their families,
bringing with them the health problems which beset the
socially disadvantaged.
Important effects of all these stressors have included a
decline in medical scheme membership (D.Kolver, Registrar
of Medical Schemes - personal communication) and a
move by the insurance industry to design and market
products for the low-risk and relatively healthy young
population.
In contrast to the opinion expressed by Price and
Masobe! the view within the medical schemes industry is
that the amended Act has positive and negative aspects.
Positive features of the amended Act
Under the old Act, employers and scheme members would
increasingly have moved away from medical schemes in
response to rampant premiums, and would have sought
more limited health care cover elsewhere. The new Act
allows schemes greater flexibility in the design of the
packages, in line with the preferences of existing and
potential members. For example, this will enable schemes to
introduce an essential health care package as an affordable
product which will appeal to those at low risk who do not
want catastrophic cover for themselves or their families.
Such a move not only diminishes the burden of cost for
employers and existing members, but also casts the health
care net wider by making it more accessible to lower-income
groups. At the the other end of the spectrum, packages will
be available for those in the higher-income brackets who,
notwithstanding youth and health, seek the 'luxury' of
catastrophic cover and forward funding.
These 'designer policies' will typically be introduced in an
evolutionary rather than a revolutionary manner. A policy of
revolution, in which schemes abandon those at risk, would
result in medical, social, political and financial distress, if not
disaster. At the end of the evolutionary process we will be
left with a private health care funding system which
superimposes on an essential health care package mixed
combinations of cross-subsidy medical plans, long-term
prefunding plans, and personalised savings plans. The
ultimate objective is to recreate the risk pool in an adequate
but different form from that which existed in the past.
Other positive features of the Act are the ability of medical
schemes to enter into contractual relationships with
hospitals and professional health care providers, and the
ability of schemes to metamorphose from claims
processors into critical analysts of where and how the
budget is being spent. Ruff has written on the positive
aspects of managed health care in the South African
situation, while the advantages of clinical audit and quality
assurance have also been well documented.s Managed
properly, medical schemes will become effective participants
in the delivery of health care, sensitive to the needs of
members and providers of service alike, but functioning
within the economic realities and limitations of South African
society. This scenario not only addresses the current funding
crisis in the medical schemes industry, but also
accommodates the sociopolitical changes as the country
moves towards equity in the provision of health care. Price
and Masobe's2 proposal for medical scheme funding of an
essential health package is an example of how the system
could not only accommodate the present, but also be
adaptable to future requirements of a national health
insurance system.
Negative features of the Act
In a competitive private sector funding market, as medical
schemes and private insurers compete for members, both
groups are likely to consider risk rating principles, particu-
larly for the chronically ill and those members who are a
significant burden on the system. These high-risk categories
may, with time, be left increasingly to public sector care.
However, it is likely that in future, the cost of care for the
aged and chronically ill will be partially offset by the
introduction of prefunded packages arranged by medical
schemes. Such packages will enable individuals to set
aside money while they are employed, specifically to defray
health costs after retirement.
On the other hand, one might argue that this is not a
negative result. Perhaps it is desirable to channel at least
certain high-risk categories into the public sector, e.g.
patients with renal failure requiring dialysis and/or
transplantation, patients with complicated diabetes or
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sufferers of various inherited disorders. The objective of care
for such categories in the public sector would be
management in academic environments in which clinical
expertise is combined with economies of scale to provide
high-quality, cost-effective health care. This approach would
enable medical schemes to continue funding high-risk
members while keeping premiums at a manageable level.
An alternative to medical scheme payments to the public
sector on a fee-for-service basis for care provided to the
high-cost categories, would be care on a capitated basis,
where schemes would contract with academic centres to
provide certain services to all eligible patients for a fixed fee.
It may well be argued that physical or human resource
constraints will limit the viability of the public sector high-
care option. The response could then be to extend care to
the private sector, but for such care to be under the
supervision of academic specialists who would apply clinical
guidelines and therapeutic protocols as in the academic
centre, and utilise drugs purchased within the state tender
system.
Responsibilities of employers and medical
schemes
It is the belief of the medical schemes industry that the
argument which claims that changes to the Act will result in
large-scale shedding of chronically ill and aged patients is
almost certainly overstated. Employers have in most cases
assumed a moral obligation towards retired and soon-to-be
retired employees. Employers will therefore seek out
schemes which offer continuation benefits at reasonable
prices, and will continue to support these schemes for as
long as their obligation to pensioners exists and they are
financially able to meet their commitments. However,
employers are also likely to respond to changes in the Act
by demanding that medical schemes and insurers provide
funding options which set aside appropriate reserve funds
and are geared to meeting future health costs.
. Medical schemes are also likely to explore options in
terms of health care delivery systems, and are likely to
operate more along contractual lines in order to ensure that
obligations are met within the constraints of limited budgets.
While this will involve greater sophistication in the area of
financial management, it will also require access to and
analysis of high-quality computerised information. Systems
linking schemes to hospitals and providers will capture data
which will ultimately facilitate transparency, utilisation revie"!,,
clinical audit and peer review, and which will foster quality
assurance, cost coni:ainment and improved use of limited
resources.
Recommended policy for enhancing tf!e
cover offered by medical schemes
Taking into account the positive and negative aspects of the
amendments to the Medical Schemes Act, the needs of
employees and the responsibilities of employers, the
following approach will most likely be adopted by medical
schemes to promote and provide appropriate basic/essential
health cover for all members:
- It should be necessary for all employed people and
their dependants to obtain financial cover for at least a basic
(essential) package of health care. The employers' medical
schemes should be required to offer full cover for these
services.
- As regards the basic (essential) package, no medical
scheme should deny enrolment to any applicant because of
health, employment or financial status, nor should they
charge some patients more than others because of age,
medical condition or other factors related to risk.
- In respect of cover relating to the basic (essential)
package of health care services, any competition between
medical schemes should be based upon quality and service,
not on selection of low-risk consumers.
- All medical scheme options should be required to offer
full cover for these basic services.
- All medical schemes should be required to meet
certain minimum financial reporting, auditing and reserve
requirements.
- All medical schemes should be required to collect and
submit relevant data in order to facilitate planning at I(')cal,
provincial and national levels. ..'
- Medical schemes should be allowed to offer coverage
for services not included in the basic/essential health .care
package, subject to appropriate regulation relating to certain
specialised equipment, technologies and facilities, which
may be introduced from time to time. For example, this
regulation may require medical schemes to purchase certain
high-level specialised services from public sector facilities,
such as academic centres. In this way, the teaching,
research and clinical service functions of these facilities
can be strengthened for the long-term benefit ~f all SO!Jth
Africans.
- A system of state subsidies could be iRtroduced to
ease the burden on small employers and eligible IQw-income "
emp"loyees.
- In the event of liquidation of a medical scheme, claims
relating to basic/essential services shoulg pe preferent
claims.
- All medical schemes could be required to participate in
a risk equalisation fund to ensure that no medical scheme
faces an excessive claims burden arising fr-om the policy
listed above. This fund would apply in respect of the
qasic/essential health care p-,!~ka~E? .
The ANq Natio!1CJ!! 14~~/tfl Plan for South
Africa
On the eve of a nevy, ~uit~gle h~alth dispensation, are the
ab9ve comments and proposals of any value? How, if at all,
caR t~e mediC;g! §ehiriJes'r~sp~nd' constructively to the
amenclfTlentl? t~ t!'l~ M.edical Schemes Act, and also to an
ANC yision wn'f:h RiscofJrages expansion of the private
l?~9tor, I?r@~@l?~? r8§l4Ia!ory mechanisms, and promotes the
C9flSid@mti~Fl of alternatives such as compulsory social
!nsl}ram'i~ f9f ?I! form~1 sector employeeS and their
dependeF!!§, It i§ tre belief of the medical schemes industry
that tA~f@ e.f@ §~YE?ra! arE??~ iF] which the private and p'u!?lic
sectors can work together to promote health and health
care.
It should be acknowledged that professional excellence,
while not always in synchrony with the national health
needs, is indeed present in the private sector: medical
expertise, administrative structures, information systems and
review processes are all in place. These must not be
underestimated or ignored, and should be retained,
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Fig. 1. Impact of removal of the tax subsidy on private health






















In coming to terms with the amendments to the Act and the
ANC policy document and both of these in relation to the
needs of South Africa, we must recognise the commonality
of purpose, and commit the private and public sectors to
co-operation and integration at the appropriate levels. The
ANC mission, which is 'to design comprehensive
OF------+----+------+---=~;I;
- 2 000 110 ~OcurrentPOSit::, i.e. with SU:~dY in place 50
-D---- Income after VAT
however, such a move is likely to accelerate the process of
collapse, not retard it. As the process advances, the
government tax gains start to diminish, the private sector's
after-tax earnings fall even more dramatically, and an
increasing number of patients and providers turn to the
State for assistance.
The 1993 World Development Report" argues that
universal government financing of an essential package
leads to public subsidies to the wealthy, who can afford to
pay for their own services. The Report argues that a policy
of concentrating public resources on service for the poor
and requiring others to pay all or part of their own costs
makes sense on equity grounds (although there are
disadvantages). The Report suggests that in middle-income
countries, where a significant part of the population may be
covered by private or social insurances, governments can
target public monies to the poor by legally defining and
mandating that the defined national essential health care
package be covered in all private insurance policies, thereby
freeing government resources to target the poor. Retention
of the tax subsidy would be useful if such a policy were to
be pursued.
developed and integrated into the National Health Strategy.
Perhaps the most important point to be made is that the
medical schemes and the ANC actually share an objective,
Le. the broadest possible cover by means of an essential
health care package. However, whereas the schemes focus
on the privately funded sector and seek to pay for the basic
package from funds generated by employer and employee,
the ANC is in favour of the package being available to all
South Africans, funded by a national health system or
insurance. As mentioned earlier, Price and Masobe2 make a
case for the retention of the short-to-medium-term medical
scheme option and explain how this could be transformed
over a period of time into the nationally funded option.
Accepting Price and Masobe's view, and given the serious
commitment of the medical schemes industry to accept
responsibility for health and health care, the funds necessary
for the interim cover should continue to be supported by tax
concessions, at least in the short and medium term.
The employer contribution to a registered medical scheme
is not taxed in the hands of the employee. Generally this
contribution amounts to 50% of the total medical aid
contributions. The tax saved by the employee on this
employer contribution will vary from one employee to the
next, and will therefore depend on the marginal rate of tax
attributable to each employee. It is this tax saving which we
refer to as the tax subsidy.
The employer contribution to a registered medical aid is
tax deductible as a business expense incurred in the
production of income. This is not regarded as a tax subsidy.
This is because any attempt to deny tax deductibility will
cause an employer to add his expenditure back to employee
income, and call it 'salary' or 'wage'. In this way the
expenditure will remain tax-deductible.
Abolition of the current tax subsidy would almost certainly
have a profound effect on medical schemes as members
downgrade policies or abandon schemes altogether. In
general, members would not be able to maintain their status
because of the additional contribution they would have to
make from their salaries after loss of the subsidy and their
having to pay tax on the portion of the premium previously
paid by employers. Loss of membership not only threatens
schemes, as described earlier in this' paper, but threatens
the private health care providers as well. There is also the
likelihood that those who drop out of schemes would
become dependent on the public sector for health care,
thereby adding to the burden of an already stressed system.
In Fig. 1 we show the present situation in terms of medical
schemes expenditure. Critical data are the earnings-after-tax
figures, provider costs, and the government tax information.
The effects of various reductions in medical schemes
contributions (Which obviously translate into reductions in
both expenditure and membership) can be seen in respect
of the critical data sets: as membership and expenditure fall,
fixed costs remain constant, but taxable earnings and
earnings after tax plummet. Granted, at lower levels of loss
of membership and expenditure, the government tax
revenue increases, but probably at the cost of collapse of
some providers (medical schemes, hospitals, pharmacists
and doctors). Furthermore, the tax gains are likely to be
offset· by the increased number of patients presenting to the
public sector. Certainly providers could attempt to delay
their collapse by overservicing the remaining patients;
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programmes, reduce waste, increase efficiency and promote
greater control by communities and individuals over their
health and health care, respecting human rights and
promoting accountability to the users of health facilities and
the public at large',s applies equally to medical schemes and
their members. Furthermore, integration of the sectors can
be achieved without sacrificing the ANC's stated objectives
of promoting capitation v. fee-for-service, dissociating
income from volume or brand of medication prescribed, and
ensuring quality care.by peer review, clinical audit and the
development of therapeutic guidelines. In fact, review of
recent medical schemes literature will reveal that all of the
above strategies have been considered if not already
included in various packages and programmes. Co-
operation and collaboration make eminent sense, and
medical schemes are making it known that they are willing
and able to take their place as participants in the national
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SPECIAL ARTICLE
Fifty years of nutrition
research - past work
contains the key to future
strategies
In this article, on the 25th anniversary of the Medical
Research Council (MRC), we show how medical research in
the field of nutrition conducted in this country has come full
circle. From a strong foundation in community-based
research in the 1940s and 1950s and pioneering work by
primary health care (PHC) researchers whose work became
world-renowned, to an increase in laboratory-based
research in the 1960s, 1970s and part of the 1980s, there is
now a return to a PHC approach in the 1990s. We trace the
historical development of the MRC's nutrition research from
the medical units based at the Council for Scientific and
Industrial Research (CSIR) to the present focus on essential
national health research (ENHR) aimed at directly
confronting the health problems of the country.
CSIR reports and policy documents, early MRC Annual
Reports and the publications of the period were used to
gain a clear understanding of the work being done and the
change in direction. We also consulted researchers active
during the 1940s and 1950s (Sidney and Emily Kark, Mervyn
Susser and Alex Walker). At a time of major restructuring in
this country, it seems opportune to learn from the past. This
article complements the Yach and Tollman' theme of
learning from public health initiatives of the past to create a
more equitable health system in a post-apartheid era. We
focus on nutrition research because there is a strong sen_se
of continuity between the work done by nutrition research
groups in the 1950s and work today.
What exactly is meant by PHC or
community-based research?
The PHC apprqach emphasises equity and social just{ce
and forces researchers to look at the real beneficiaries of
research and not to conduct research only for its own §ake.
These concepts were developed in the late 1930s and
early 1940s by South African pioneers such as Drs R. A.
Dart, J. and T. Gillman, E. H. Cluver, H. S. Gear, G. W. Gale
and Sidney and Emily Kark and colleagues, who were then
re-evaluating traditional approaches to public health and
reaching a very sophisticated, holistic view of health.
'Further, they built upon their causal explanations when
defining appropriate health interventions, and in so doing
went beyond the selective and simplistic approaches to
health that have characterised global pUblic health strategies
of the 1980s." These pioneers were directly responsible for
much of the early work in some of the CSIR medical units.
This pioneering spirit of public health was not confined
to South Africa, and the 1940s saw the development of
national health services in a number of countries. The
Beveridge Plan, for example, outlined a welfare state
including a national health service for post-war Britain.
South Africa was active in the World Health Organisation
(WHO) from its beginning in 1948, and this meant that great
value was attached to applied research and community
involvement.
Gear, Brock and Kark all served on early WHO
commissions_
A brief history of medical research in
South Africa
Research direction and application over the years has
reflected the political and social priorities and goals ofthe
dominant forces. This has led to advanced technological
capacity in laboratory sciences (as evidenced by the heart
transplantation programme and proton therapy) in the face
of high levels of preventable mortality and morbidity and
considerable inequity in health status and the distribution of
resources needed for development.
In 1977 John Brock wrote, 'Medical research must, to
justify the name, be consciously directed towards an end -
the alleviation or cure of human illness and its ultimate
prevention. It is basically a field of applied research!
The South African Institute for Medical Research (SAIMR)
was founded in 1914, at the same time as the founding of
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the Chair of Medicine at the University of Cape Town (UC1)
(1912 - 1914).
The SAIMR initially did a great deal of work on the
diseases affecting mineworkers and also investigated
infectious diseases. A strong tradition of research was
established, but funding was poor until the post-war years,
when the CSIR (which was created by an Act of Parliament
in 1945) was given a brief from the government to 'explore
and develop the whole field of medical research'.3 After
thorough investigation the CSIR decided that rather than
operating its own research, it would provide funds to
existing research bodies and researchers. An annual grant
was made to the SAIMR and support was given to 20 units,
groups and projects based at the medical schools and
universities. This was managed by an expert committee, the
Medical and Dental Research Committee, the seminal MRC.
The 1949 Annual Report of the CSIR described these
medical research units as follows: 'One of the most
important activities on the Council's programme has been
the development of research units, housed where most
appropriate, and built around individuals competent to do
the work. Problems of national importance have received
priority. '4 Similar sentiments were used to describe the
establishment of the MRC's National Programmes in 1992:
'Through the formation of national collaborative
programmes, skills and resources will be rationalised in the
quest to find solutions to the health care problems of the
population."
Two of the units formed in the late 1940s, the Clinical
Nutrition Research Unit and the Family Health Research
Unit, initially had a strong PHC approach, and we focus on
their activities.
Clinical Medicine Research Unit
The Clinical Nutrition Research Unit started its life as the
Social Medicine Research Unit at UCT under the direction of
Professor John Flemming Brock (1905 - 1983). Described as
the clinical father of South African medical research," he
occupied the chair of medicine at UCT for 30 years. He saw
health and disease as the result of many environmental,
psychosomatic and genetic factors, but most importantly as
the result of the quantity and quality of the food we eat.
Work in the Unit was influenced by this philosophy for
many years.
The Unit's initial research programme iflvolved a controlled
cross-section of the white and coloured populations of the
Cape to establish rates of morbidity and mortality for the so-
called 'social diseases' such as tuberculosis, eclampsia,
infantile bronchopneumonia and gastro-enteritis, to ascertain
the nutritional status of each group and to investigate other
social factors such as housing and education which impact
on these rates.4
In 1949 Brock' published a comprehensive outline of the
pattern of health and disease encountered in the Cape
Coloured population in the SAMJ. His study revealed that
tuberculosis and pneumonia, diarrhoea and gastro-intestinal
illnesses were the major causes of death, in contrast to the
European population in which heart disease and cancer
were much more prevalent. He pointed out that the 'social
diseases' are particularly prevalent in the population at the
lower end of the socio-economic scale: 'those diseases in
which the most important aetiological factors are deficiency
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of health-promotive factors, particularly food, exercise,
sleep, warmth, air and cleanliness'.' The article points out
that the necessary remedial action must lie in an
improvement in socio-economic status and, to some extent,
in the hands of the people themselves.
Family Health Research Unit
By this stage Sidney Kark was well known in the field of
community health care. During the 1940s and early 1950s
an interesting and extremely successful PHC experiment
was undertaken by the government at the Polela Health
Centre in Natal. It was initially conceived by Drs E. H. Cluver
and J. H. S. Gear, Chief Medical Officer and Deputy Chief
Medical Officer, respectively, of the Ministry of Health. Or
Sidney Kark was appointed in 1939 to direct and initiate this
pilot project. He, together with his wife, Or Emily Kark,
Edward Jali (a Fort Hare graduate medical aide) and his wife
Amelia Jali (a state-registered nurse graduate of McCord
Zulu Hospital, Durban) were the founding team of the Polela
Health Unit. Shortly afterwards 5 malaria assistants were
sent to join the team, and underwent intensive retraining to
become community health field workers and later commu-
nity health educators.
The Polela Health Centre was internationally advanced for
its time. It aimed to provide both preventive and curative
services. Interventions were based on sound
epidemiological foundations and an understanding of the
social context of health and disease. Progress was rapid,
especially the decline in a high infant mortality rate, the
improved growth and clinical nutritional status of infants and
young children in the community, and the control of
infectious diseases. Measurement of all activities and birth
and death notifications were introduced in consultation with
the community.
This work strongly influenced the recommendations of the
Gluckman Commission of 1944, follOWing a visit by
commission members to the health centre in 1943. The
commission (1942 - 1944) had as its stated aim 'to produce
a plan for a national health service designed to promote and
preserve the health of all sections of the people in
accordance with modern standards. '. The report described
the existing health service-as fragmented and over-
emphasising curative as opposed to preventive approaches.
The Commission proposed a unified national health system
with community health centres as its building blocks.9 In
fact, the establishment of community health centres was the
only recommendation that reached any level of
implementation.
One of the earliest decisions of the Health Centre Advisory
COmmittee was the establishment of an institute to train
personnel for the future health centre service. This was
established in Durban in 1945 and was later named the
Institute of Family and Community Health (IFCH), with
Sidney Kark as its initiator and director. This required
transfer of the Karks and some of the Polela Health Centre
staff to Durban. Polela was incorporated as the rural
research and training base of the IFCH and was expanded
by an increase in staff and accommodation. Six practising
health centres were established in Durban as a community
base for field experience of trainees and for research in
family and community health. Community health
programmes were based on the ongoing use of
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epidemiology in practice, in relation to the clinical findings
anq way of life of the individuals and families in the
community - all the homes in a defined area were
included, not just the homes of patients.
The remarkable success of the health centres was
reflected in a considerable improvement in health status,
including infant health and survival, reduction in clinical
malnutrition and preventable infectious diseases (including
sexually transmitted diseases), and the almost complete
eradication of smallpox, typhoid fever, whooping cough and
the nutritional manifestations of measles. There was also
marked progress in the people themselves, who became
active in the promotion of their own health.
In the latter part of 1948 and early 1949, Professor Sarel
Oosthuizen, chairman ·of the medical research section of the
CSIR, visited the IFCH with Or George Gale, Chief Health
Officer of the Health Ministry. After this visit the CSIR Social
Medicine Research Unit was established at the IFCH in
1949. The name was later changed to the Family Health
Research Unit. It included two sections: (I) studies in growth,
development and nutritional status of South African girls
with particular reference to puberty, with Or Emily Kark as
the CSIR bursar for this section; and (if) studies on birth
weight and subsequent development in South African
babies, with Or Eva Salber the CSIR bursar, assisted by
Evelyn Bradshaw.
Studies on growth, development and
nutritional status
A number of studies looked at sexual maturation through
puberty in girls from different ethnic, racial and social
backgrounds. The various studies showed significant
differences in age at menarche between the different groups,
with the mean for urban Indian girls over 6 months earlier
than that for their black counterparts.,o-l'
Emily Kark's study13 on the growth and nutritional status of
black girls in Durban was published by the South African
Journal of Medical Science in 1953. The study involved a
complete clinical examination of a group of urban black girls
in Lamontville followed by a feeding experiment which
studied the influence of a daily milk or syrup supplement on
growth and nutritional status. There was a consistent and
significant improvement in the clinical status over the course
of the year, showing that nutritional supplementation
undoubtedly leads to improvements in growth and health in
children.
Birth weights of South African babies
The classic series of studies on birth weight and
subsequent development were conducted by Eva Salber
and Evelyn Bradshaw, and various articles appeared in the
SAMJ," the British Journal of Preventive Social Medicine'5-'·
and Human Biology, '9 among others. The findings were very
much in line with similar studies today. 'It is suggested that
the birth weights of European and non-European babies
may be strongly affected by both economic and cultural
factors. The differing economic levels and nutritional states
in the four racial groups largely determine the differences in
mean birth weight, incidence of prematurity and seasonal
variations in birth weight found. Cultural factors such as age
at childbirth, number of children born, and the use of
contraception again make for differences in the populations
observed.'''
In a study of babies at Polela conducted by Sidney Kark it
was found that although during the first 3 months of life the
Polela babies' weight gain was equal to that of British and
American white and black middle-class babies, after the age
of 3 months there was a decided lag in this growth
compared to the other groups.'" This was corrected by a
special community health programme which focused on the
early signs of infant malnutrition. A similar change was
effected in the weight growth of Indians in the Merebank
community of Durban, but in this community the
improvement was even more evident in girls than in boys,
especially in the second half of the first year of life.
New name, new directions?
In 1951 the Cape Town group opted for a new name, which
confirmed its status as a completely separate research
initiative and to some extent laid the basis for the change in
focus that was to occur. The Cape Town group regarded
the term 'social medicine' as too vague and 'ill defined'
(unpublished CSIR reports, MRC file 6/13) and changed its
name to the Clinical Nutrition Research Unit. The Annual
Report emphasises that 'the change in name should not
involve a change in the "social" approach to the problem
under investigation'."
Support terminated
The death blow to the Durban group's work came with the
government's decision to withdraw from funding the Institute
in 1955. It was temporarily saved by an action by the
Principal of the University of Natal, Or E. G. Malherbe, and
Or George Gale, then Dean of the FaCUlty of Medicine, who
were successful in obtaining a 5-year grant from the
Rockefeller Foundation. This grant was to finance the
Department of Social, Preventive and Family.Medicine at the
University of Natal, which was fully integrated with the IFCH.
At that time it was the only university department in the
country which offered a 3-year clerkship based on family
practice. After the government's decision to stop financing
the IFCH the CSIR Unit was also closed, on 31 March 1956.
The Karks emigrated to the USA in 1958 knowing that
after the termination of the Rockefeller grant the government
would not support the IFCH or the university department
integrated with it. Kark had faced increasing official
opposition to his work and had even been investigated for
communist activities in the 1940s after distributing dried
skimmed milk to malnourished children." According to Kark
(personal communication, 1993), the multiracial health teams
of men and women, the less formal setting at the Institute
and the respect given to patients no matter what their race
or background offended many.
The period of 'grand apartheid' initiated with the rise to
power of the National Party in 1948 led to a retreat from
world public health fora and an increased emphasis o"n high-
tech research and curative interventions. The public health
research emphasis on equity challenged the apartheid policy
and led to a flight of public health expertise. Table I lists a
few South Africans who emigrated between 1948 and 1960
and later attained high office in public health internationally.
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Table I. Ten South African public health researchers who
emigrated between 1948 and 1960
Sidney Kark Spent time in Chapel Hill, North Carolina,
then moved to Jerusalem.
all ages. An interesting problem still encountered today was
also highlighted: 'It is a sobering thought too, that the
sophistication of diet which is taking place among privileged
people is probably leading to the incorporation of more and
more carcinogenic substances in processed foodstuffs. In
other words, if by better dieting we can prevent cancer of
the liver in underprivileged people, are we merely going to
substitute another form of cancer resulting from sophisti-
cated and highly processed foodstuffs?' The association of
high-fat diets with cancers of the colon, breast and prostate,
and the possible protective effects of high intakes of fibre
and vitamins C and E for certain cancers, suggest that this
may be true. However, food additives have not been shown
to contribute significantly to increased risk of disease."
Dietary fat and coronary disease
Studies on dietary excess and deficiency were
simultaneously undertaken by the Unit, with a change in the
balance occurring over the years favouring research into the
nutritional impact of excess in white populations. There was
increasing emphasis internationally on research on
ischaemic heart disease (IHO), particularly in the USA, and
this undoubtedly influenced the direction of local research.
The unit therefore embarked on a project to investigate
serum cholesterol and dietary fat, with particular reference
to coronary thrombosis. This was a long-term study
investigating the effect of saturated and unsaturated fats on
serum cholesterol levels. 'The nutritional and metabolic work
in this field is being done against a background of the
enormous prevalence of ischaemic (coronary) heart disease
in white South Africans who are second in world statistics
only to the USA in mortality from this disease. '25 The report
for that year also stresses that 'dietary factors have to be
taken in relation to admitted causative factors such as lack
of exercise, tension and strain and smoking'25 (smoking is
now - over 30 years later - the subject of intense
international and local study). It points out that other factors
such as race, family and sex are outside public health
control but that the low prevalence of IHO in the black
population suggests that mortality among whites could be
reduced if the operative causes could be identified and
corrected. A number of publications on the effect of dietary
fats on IHO and coronary heart disease were written by
Gordon (a bursary holder in the Unit), Bronte-Stewart and,
Brock, and were published in the British Medical Bulletin, 26
the Central African Journal of Medicine,27 The Lancet!" The
Practitioner 29 and the SAMJ. 3o Failure to implement these
research findings in the public health arena meant that as
IHO rates in the white population declined, rates in the
coloured and black populations increased.
As the 1960s progressed, the swing towards more
experimental, laboratory-based work in the Unit became
much more obvious. Writing in the SAMJ in 1958, Brock31
outlined the history of nutrition research in the world and
in South Africa in particular and stated: 'It suddenly
appears that those of us who felt that nutrition was a field
for scientific enquiry in its own right, and for its possible
significance in relation to human health and disease, were
not deceiving ourselves. Research into the nutritional
aspects of disease has suddenly become exciting and
intellectually rewarding.'
Developed the concept of PHC for the WHO.
Now both retired.
Both went to Columbia University, New
York, where they played key roles in public
health in the USA. Both are now emeritus but
are actively involved as advisers to the MRC
- particularly to the Centre for
Epidemiological Research in Southern Africa
(CERSA) and the AIDS Programme. Mervyn






Went to Chapel Hill, North Carolina, where
she was a pioneer in the field of paediatric
public health.
Played a key role in policy development in
public health. Now retired.
Harding le Riche Became Deputy Minister of Health, Canada.
Now retired.
Henry Phillips
George Gale Became Professor of Preventive Medicine at
Makere University in Uganda and then WHO
Visiting Professor of Public Health in
Bangkok, Thailand, and at the University of
Kuala Lumpur in Malaysia. He finally retired
to London,where he died in 1976.
John Cassel Regarded as playing a legendary role at
Chapel Hill in the field of social epidemiology.
Delivers a prestigious annual lecture at the
American Epidemiology Meeting.
Sidney Shapiro Professor of Epidemiology at Boston
University. Now collaborates with the CERSA
and has regularly visited South
Africa since 1990.
Studies on kwashiorkor
The Clinical Nutrition Research Unit in Cape Town continued
to produce high-quality research. Brock' s work in the field
of kwashiorkor had been recognised internationally when he
was appointed by the WHO Joint Expert Committee on
Nutrition to undertake a further study. This work led to
tremendous international interest in the effects of poor
quantity and quality of protein and vitamin deficiency, and
fostered collaboration with other African countries. Appro-
priate research in South Africa was thus receiving inter-
national recognition and funding which could be used to
undertake more research.
In a paper published in The Leech in 1958,23 the
researchers stated that on the African continent the
widespread protein malnutrition which produces kwashiorkor
must also be one of the reasons for the high prevalences of
adult cirrhosis and of primary carcinoma, but that the
relationship is not necessarily direct or sequential. Improved
diets recommended for the treatment of kwashiorkor would
undoubtedly lead to the correction of protein malnutrition at
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CSIR to MRC
The CSIR established a National Nutrition Research Institute
in 1954, which worked in the fields of nutrition and food
research. It was to some extent an amalgamation of a
number of smaller nutrition research groups - particularly
one under Or A. R. P. Walker at the SAIMR and another
under Dr J. Gillman at the University of the Witwatersrand,
which had undertaken interesting work in the preparation of
a medical geography of nutritional diseases in the country,
the establishment of the complete natural history of
malnourished subjects from birth to death, the effect of
malnutrition on the evolution of diseases, nutritional
techniques and bio-assays of foods.
Commission of Inquiry into Medical
Research
In 1954 a proposal was made by the Union Health
Department that the CSIR should take over all medical
research being conducted within the Department. It was
recommended that a commission of inquiry be appointed.
The commission was to investigate and report on: (I) the
possibility of better co-ordination of medical research in the
Union, possibly under one body; (il) the possibility of
bringing about such co-ordination under, or as part of, an
existing statutory body, and (iiJ) the necessity or otherwise
for the establishment of a new independent body to co-
ordinate medical research. The brief went on to include such
matters as to whom an independent body would report and
the constitution, powers, duties and financing of such a
body."" The first glimmerings of the MRC of today appeared.
By the 1960s it had become very clear that a separate
body was needed for the control and support of medical
research. A report by the CSIR's Advisory Committee for
Research and Co-ordination, 'Current status of research in
the medical sciences' (unpublished, MRC file M6/1/2/1 b
vol. 1), compiled in 1967 - 68, mentioned the strong possibi-
lity of the establishment of an independent statutory body,
pointed out some of the observed changes in medical
research, and made recommendations for the future.
Interestingly, it states: 'In broad terms it is preferable that
research has a goal and that this should be linked to the
problems of the country. On the other hand, research of any
nature constitutes a growth medium for the development of
scientists, it creates an environment in which there is a
conscious desire to find answers to the unknown, and it
serves to attract and keep personnel for training centres.
The value of clinical research also tends to be
underestimated. There is increasing emphasis on the
laboratory and the more basic aspects of medicine.'
(Translated from Afrikaans.)
The MRC was founded in 1969 and took over some of the
medical units, groups and short-term workers supported by
the CSIR as well as sections of the National Nutrition
Research Institute. The National Institute for Nutritional
Diseases was founded and initially functioned under the
leadership of the Vice-President of the MRC, Dr J. J. Theron.
In the first year, Or I. F. H. Purchase was appointed as
Director. The Institute was divided into the following
divisions: Medical Statistics and Epidemiology, Physiological
Chemistry, Toxicology, Medical Biochemistry, and child and
adult clinics. The most important research projects in the
first few years were studies on kwashiorkor, Mseleni hip
disease and an investigation of the causes of liver cancer
focusing on the mycotoxins (laying the basis for recent work
which has gained international acclaim).
The first MRC Annual Report of 1969 - 70 outlines the
goals and activities of the institutes, units and groups and,
interestingly, describes the function of the Clinical Nutrition
Research Unit as 'research into the relationships between
food, health and disease at clinical and laboratory level.'33
The main projects described concerned protein catabolism
in the study of kwashiorkor using an animal model, the roles
of saturated and unsaturated fats in levels of serum total
cholesterol, and the mechanics and pathogenesis of
atherosclerosis.
Twenty-eight research projects were terminated at the end
of 1972,34 and with the loss of overseas funding and the
impending retirement of Brock, the Clinical Nutrition
Research Unit was finally closed. The National Resear~h
Institute for Nutritional Diseases then became the major
focus of nutritional research in the MRC.
Framework autonomy
The system of 'framework autonomy' introduced by the
government in 1987 profoundly influenced the functioning of
all the statutory research bodies. 'In terms of the policy the
5 statutory councils (the MRC, CSIR, Human Sciences
Research Council, Mintek and the South African-Bureau of
Standards) will have greater freedom in managing their own
affairs. However, they will also be dependent on contract
research and services, rather than direct state funding, for a
larger proportion of their funds.'35 Research was required to
be more marketable and also to have potential for
application without ignoring the important role of
fundamental research.
All of the statutory bodies have received criticism over the
years for not conducting research with specific goals
emerging from sufficient discussion with the disadvantaged
communities whose .needs are to be met.'" Current
development of a future science and technology policy
indicates that this criticism is being actively addressed.
The MRC Board
The composition of the MRC Board has been a barometer of
both changes within the organisation and the wider socio-
economic and political changes. The early Council members
(and institute directors) were white and male. Further, most
were based in the university medical schools. Even today
the universities have not developed sufficient expertise in
public and community health. 'The universities, particularly
medical schools, have fallen far short in providing the
institutional backing and intellectual leadership so needed to
pioneer future directions in primary health care and
community-based health services." The group determining
research direction in the MRC was therefore far from
representative of the population. The demise of international
links (South Africa was suspended from the WHO in 1974
and was not included in the Alma Ata declaration in 1978)
had also inevitably led to a more inward-thinking perspective
and the preponderance of laboratory-based work. 'The
research conducted by the MRC's own staff, or funded by it
in the universities, traditionally focused on biomedical
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research responding to the research needs of individual
researchers who were judged on their track records as
researchers rather than on the basis of any assessment of
the health needs of the population as a whole. '36
The changes made clearly show a start in the quest for
more equitable racial and gender representation. Also
notable in the current MRC Board is the inclusion of
community health specialists' and social scientists, reflecting
the awareness of the need for health services research.
Essential national health research a
return to the past?
The extensive restructuring of the MRC undertaken from
1990 reflects the political and social changes in the country.
There was a growing awareness that every country should
have the ability to define its major health problems and their
causes, and to recommend interventions to improve health.
The Department of National Health and Population
Development (DNHPD) embraced a PHC approach in 1990,
and this has forced researchers to look at the real
beneficiaries of research.
It became increasingly clear that owing to funding
restrictions, all research, whether laboratory-based or
community-based, has to be mobilised to the overriding
goal of improving health. Research for the sake of research
is no longer justified in a country with many pressing health
problems. The global strategy of ENHR was therefore
adopted. ENHR is an integrated strategy for organising and
managing research. Its goal is to promote health and
development on the basis of equity and social justice. It is
specifically orientated toward the most important problems
affecting the population, with particular emphasis on the
poor, the disadvantaged and other vulnerable groups whose
health needs are often overlooked. The DNHPD, the African
National Congress and the Medical Association of South
Africa have all endorsed ENHR. National programmes
reflecting the disease priorities of the country were
established by the MRC. The aim was to create a balanced
research portfolio which included basic research at a
molecular level and clinical work right up to community-
based, highly applied policy-relevant research.s
The overriding goal of ENHR is encapsulated in the slogan
'Health for All,' coined at A1ma Ata in 1978. Attaining this
requires political commitment, public participation, realistic
regional and national goal-setting, upgrading the skills of
health professionals, redefining the role of the government in
the health sector and taking full advantage of technological
opportunities. The essence is a dynamic partnership
between policy-makers and service providers, researchers
and community members."
National programmes created by the MRC 'for the first
time consist of public health specialists; social scientists and
other related researchers participating, with their biomedical
colleagues, in programmes aimed at addressing the public
health needs of communities.36
The challenge of the future will be to adopt the essential
elements of ENHR fully, which include: promotion and
advocacy, priority setting, capacity building and
strengthening, networking, financing and managing and
evaluating.38 There is a crucial need to work with the other
statutory councils, the DNHPD and non-governmental
organisations. The MRC cannot encompass the whole
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health arena, but should strive towards building strength in
certain areas and building capacity for excellence. To do
that it has to build on the lessons of the past and
incorporate them into a new, wider perspective for the
future.
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